Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors

November 7, 2023 updated by: Johns Hopkins University
This study utilizes a web-based application to help patients on the organ transplant waitlist communicate patient's need for a living donor via social media and provide interested potential donors the opportunity to engage with the evaluation process.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

Barriers to identifying a live donor include lack of education and hesitance to initiate a conversation about live donation. For these reasons, many transplant candidates are hesitant to discuss candidate's illness and are therefore reluctant to pursue live donor transplantation. The investigators hypothesize that utilization of social media to spread awareness about candidate's illness and candidate's need for a live donor will enable many transplant candidates to successfully identify live donors. In this study, participants will use a novel web-based application, called the "Donor App", to create and share candidate's story via Facebook and other social networks to assist in the search for a live donor.

Study Type

Interventional

Enrollment (Estimated)

1000

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • California
      • San Diego, California, United States, 92037
        • Enrolling by invitation
        • Scripps Green Hospital
    • Connecticut
      • New Haven, Connecticut, United States, 06520
        • Enrolling by invitation
        • Yale University
    • Illinois
      • Chicago, Illinois, United States, 60612
        • Not yet recruiting
        • Rush University Medical Center
        • Contact:
          • Sherri Loeb, BSN
    • Maine
      • Portland, Maine, United States, 04102
        • Enrolling by invitation
        • Maine Medical Center
    • Maryland
      • Baltimore, Maryland, United States, 21218
        • Recruiting
        • The Johns Hopkins Hospital
        • Contact:
        • Principal Investigator:
          • Andrew Cameron, MD PhD
    • Missouri
      • Saint Louis, Missouri, United States, 63110
        • Enrolling by invitation
        • Washington University in St. Louis

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • At least 18 years of age
  • On the kidney-only or liver-only transplant waiting list at a collaborating center

Exclusion Criteria:

  • Younger than 18 years of age
  • Not on the kidney or liver transplant waiting list
  • On multiple organ transplant waiting lists

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: The Donor App
Select physicians and research staff from about 15 transplant hospitals will be given access to distribute the application to patients who the above people feel could benefit from the application. After obtaining informed consent, an approved member of the study team will enter the participant's name, contact info, and organ needed into the Donor App's secure management portal to send an email or text message with a unique and protected invitation link to the participant. Using this link the participant will be allowed to use the Donor App indefinitely.
The Donor app is a web-based application that helps transplant candidates tell the candidate's story via social media in the hopes of identifying an appropriate living donor. Sample stories created using the Donor App can be found at www.thedonorapp.com.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Potential donors identified
Time Frame: Up to 5 years
Number of potential live donors that come forward to the transplant center on behalf of the participant.
Up to 5 years
Live donor transplantation
Time Frame: Up to 5 years
Number of participants that receive a live donor transplant.
Up to 5 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
App utilization as assessed by number of participants with story completion and posting in the donor app
Time Frame: Up to 5 years
The extent of a participants story completion and posting will be recorded internally by the Donor App. The number of participants that complete stories and post will be counted to assess app utilization.
Up to 5 years
The Donor App Implementation
Time Frame: Up to 5 years
Success of the Donor App across multiple institutions will be tracked by the number of participants enrolled and invited to use the app at each institution.
Up to 5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Andrew Cameron, MD PhD, Johns Hopkins University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 27, 2017

Primary Completion (Estimated)

November 27, 2024

Study Completion (Estimated)

November 27, 2024

Study Registration Dates

First Submitted

January 9, 2019

First Submitted That Met QC Criteria

January 10, 2019

First Posted (Actual)

January 14, 2019

Study Record Updates

Last Update Posted (Estimated)

November 9, 2023

Last Update Submitted That Met QC Criteria

November 7, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on End Stage Liver Disease

Clinical Trials on The Donor App

3
Subscribe